Concepedia

Author

Nancy Paz

Merrimack Pharmaceuticals (United States)

Also Known As

N.C. Gonzalez Paz, Nancy Paz, Paz, N.

57

Publications

651

Citations

9

H-Index

36

Concepts

All Affiliations

Merrimack Pharmaceuticals (United States)Massachusetts General HospitalBoston UniversityMillennium Engineering and Integration (United States)
NP

About

Nancy Paz is an author at Merrimack Pharmaceuticals (United States) specializing in medicine, tumor microenvironment, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

300

2

Cell Biology

3

3

287

3

Engineering

2

2

197

4

Allergy

1

1

69

5

Biomolecular Engineering

1

1

184

Nancy Paz

×

9

Publications

625

Citations

9

H-Index

YearCitations

Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion

Ashish Kalra, Jaeyeon Kim, Stephan G. Klinz,

Cancer Research

2014

184

Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery

Huang‐Chiao Huang, Imran Rizvi, Joyce Liu,

Cancer Research

2017

101

Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High <i>SLFN11</i> Expression

Min H. Kang, Jing Wang, Monish Ram Makena,

Clinical Cancer Research

2015

97

Mice deficient in PKC theta demonstrate impaired<i>in vivo</i>T cell activation and protection from T cell-mediated inflammatory diseases

Karen S. Anderson, Michael Fitzgerald, Michelle DuPont,

Autoimmunity

2006

69

Use of molecular imaging to quantify response to IKK‐2 inhibitor treatment in murine arthritis

Elena S. Izmailova, Nancy Paz, Herlen Alencar,

Arthritis & Rheumatism

2006

48

Synthesis and estrogen receptor binding affinity of a porphyrin-estradiol conjugate for targeted photodynamic therapy of cancer

David A. James, Narasimha Swamy, Nancy Paz,

Bioorganic & Medicinal Chemistry Letters

1999

48

Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer

Shannon C. Leonard, Helen Lee, Daniel F. Gaddy,

Anti-Cancer Drugs

2017

34

Molecular Modeling, Affinity Labeling, and Site-Directed Mutagenesis Define the Key Points of Interaction between the Ligand-Binding Domain of the Vitamin D Nuclear Receptor and 1α,25-Dihydroxyvitamin D<sub>3</sub>

Narasimha Swamy, Wenrong Xu, Nancy Paz,

Biochemistry

2000

31

Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI)

Ashish Kalra, Joseph A. Spernyak, Jaeyeon Kim,

Cancer Research

2014

13

Page 1